Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
Prevalence of Incidental Narrowing of the Superior Segment of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system.
Allogeneic Hematopoietic Stem Cell Transplantation for Neuromyelitis Optica.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
The role of IL-6 in the expression of PD-1 and PDL-1 on CNS cells following infection with Theiler's murine encephalomyelitis virus.
Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses.
Multiple sclerosis: Repurposing dopaminergic drugs for MS - the evidence mounts.
Elevated moral condemnation of third-party violations in multiple sclerosis patients.
Molecular mimicry as a mechanism for food immune reactivities and autoimmunity.
Automated patient-specific optimization of three-dimensional double-inversion recovery magnetic resonance imaging.
Peginterferon beta-1a (Plegridy) for multiple sclerosis.
Effect of comorbidity on mortality in multiple sclerosis.
Microglia and necroptosis: The culprits of neuronal cell death in multiple sclerosis.
Simultaneous Development of Acute Disseminated Encephalomyelitis and Guillain-Barré Syndrome Associated with H1N1 09 Influenza Vaccination.
Regional Heterogeneity of Cuprizone-Induced Demyelination: Topographical Aspects of the Midline of the Corpus Callosum.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).
Cdk5 regulates developmental remodeling of mushroom body neurons in Drosophila.
[Neuropathology of multiple sclerosis].
Ischemic Preconditioning in White Matter: Magnitude and Mechanism.
Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.
Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
Assessment of ovarian reserve and Doppler characteristics in patients with multiple sclerosis using immunomodulating drugs.
Partial acute transverse myelitis is a predictor of multiple sclerosis in children.
Pages
« first
‹ previous
…
358
359
360
361
362
363
364
365
366
…
next ›
last »